advertisement
Wang C 20
Showing records 1 to 20 | Display all abstracts from Wang C91029 Prevalence, risk factors and management of ocular hypertension or glaucoma in patients with Vogt-Koyanagi-Harada disease
Yang P
British Journal of Ophthalmology 2021; 105: 1678-1682
90866 Reprogramming to recover youthful epigenetic information and restore vision
Lu Y
Nature 2020; 588: 124-129
91029 Prevalence, risk factors and management of ocular hypertension or glaucoma in patients with Vogt-Koyanagi-Harada disease
Wang C
British Journal of Ophthalmology 2021; 105: 1678-1682
90866 Reprogramming to recover youthful epigenetic information and restore vision
Brommer B
Nature 2020; 588: 124-129
91029 Prevalence, risk factors and management of ocular hypertension or glaucoma in patients with Vogt-Koyanagi-Harada disease
Su G
British Journal of Ophthalmology 2021; 105: 1678-1682
90866 Reprogramming to recover youthful epigenetic information and restore vision
Tian X
Nature 2020; 588: 124-129
91029 Prevalence, risk factors and management of ocular hypertension or glaucoma in patients with Vogt-Koyanagi-Harada disease
Pan S
British Journal of Ophthalmology 2021; 105: 1678-1682
90866 Reprogramming to recover youthful epigenetic information and restore vision
Krishnan A
Nature 2020; 588: 124-129
91029 Prevalence, risk factors and management of ocular hypertension or glaucoma in patients with Vogt-Koyanagi-Harada disease
Qin Y
British Journal of Ophthalmology 2021; 105: 1678-1682
90866 Reprogramming to recover youthful epigenetic information and restore vision
Meer M; Wang C
Nature 2020; 588: 124-129
91029 Prevalence, risk factors and management of ocular hypertension or glaucoma in patients with Vogt-Koyanagi-Harada disease
Zhang J
British Journal of Ophthalmology 2021; 105: 1678-1682
90866 Reprogramming to recover youthful epigenetic information and restore vision
Vera DL
Nature 2020; 588: 124-129
91029 Prevalence, risk factors and management of ocular hypertension or glaucoma in patients with Vogt-Koyanagi-Harada disease
Cao Q
British Journal of Ophthalmology 2021; 105: 1678-1682
90866 Reprogramming to recover youthful epigenetic information and restore vision
Zeng Q
Nature 2020; 588: 124-129
91029 Prevalence, risk factors and management of ocular hypertension or glaucoma in patients with Vogt-Koyanagi-Harada disease
Zhong Z
British Journal of Ophthalmology 2021; 105: 1678-1682
90866 Reprogramming to recover youthful epigenetic information and restore vision
Yu D
Nature 2020; 588: 124-129
91029 Prevalence, risk factors and management of ocular hypertension or glaucoma in patients with Vogt-Koyanagi-Harada disease
Zhou C; Wang Y
British Journal of Ophthalmology 2021; 105: 1678-1682
90866 Reprogramming to recover youthful epigenetic information and restore vision
Bonkowski MS; Yang JH
Nature 2020; 588: 124-129
91029 Prevalence, risk factors and management of ocular hypertension or glaucoma in patients with Vogt-Koyanagi-Harada disease
Kijlstra A
British Journal of Ophthalmology 2021; 105: 1678-1682
90866 Reprogramming to recover youthful epigenetic information and restore vision
Zhou S; Hoffmann EM; Karg MM; Schultz MB; Kane AE; Davidsohn N; Korobkina E; Chwalek K; Rajman LA; Church GM; Hochedlinger K; Gladyshev VN; Horvath S; Levine ME; Gregory-Ksander MS; Ksander BR; He Z; Sinclair DA
Nature 2020; 588: 124-129
